Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice.
Andrea FiorilloAlessandro CuomoGaia SampognaUmberto AlbertPaola CalòGiancarlo CerveriSergio De FilippisGabriele MasiMaurizio PompiliGianluca SerafiniAntonio VitaAlessandro ZuddasAndrea FagioliniPublished in: Expert opinion on pharmacotherapy (2022)
Lurasidone is efficacious in adolescents and adults in a wide range of symptoms of schizophrenia. Choosing the right dose for each patient and combining lurasidone with other medications is key to treatment success. Lurasidone has proven effective both in adolescents and adults in treating the acute phase of schizophrenia and reducing the risk of relapse. It has shown a relatively favorable tolerability profile, with minimal effects on metabolic parameters and prolactin levels.